Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-15 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 500 | $3.80 - $3.80 | $1,900 |
2024-04-15 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | A | 500 | $0.86 - $0.86 | $430 |
2024-04-12 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 19544 | $3.82 - $3.82 | $74,589 |
2024-04-12 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | A | 19544 | $0.86 - $0.86 | $16,807 |
2024-04-09 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 92787 | $3.87 - $4.14 | $369,283 |
2024-04-09 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | A | 92787 | $0.64 - $0.86 | $76,636 |
2024-04-08 | Augmedix, Inc. | Traylor Margie L.
(Director) |
A | Common Stock | A | 1244 | $4.02 - $4.02 | $5,000 |
2024-04-05 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 89167 | $3.97 - $4.03 | $357,199 |
2024-04-08 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | A | 28563 | $0.64 - $0.64 | $18,280 |
2024-03-28 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 31994 | $4.06 - $4.06 | $129,850 |
2024-03-28 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | D | 31994 | $0.64 - $0.64 | $20,476 |
2024-04-03 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 109961 | $4.11 - $4.15 | $454,453 |
2024-04-01 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 97441 | $3.89 - $4.02 | $380,106 |
2024-04-01 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
M | Common Stock | A | 51346 | $0.64 - $0.64 | $32,861 |
2024-03-28 | Augmedix, Inc. | Shakil Ian
(CHIEF STRATEGY OFFICER) |
S | Common Stock | D | 31994 | $4.06 - $4.06 | $129,850 |
2024-03-15 | Augmedix, Inc. | Faulkner Robert C.
(Director) |
A | Common Stock | A | 3125 | $0.00 - $0.00 | $0 |
2024-03-15 | Augmedix, Inc. | Green Jeremy
(Director) |
A | Common Stock | A | 3125 | $0.00 - $0.00 | $0 |
2023-12-15 | Augmedix, Inc. | Green Jeremy
(Director) |
A | Common Stock | A | 1767 | $0.00 - $0.00 | $0 |
2023-11-20 | Augmedix, Inc. | RedCo II Master F...
(Director) |
P | Common Stock | A | 1500000 | $4.00 - $4.00 | $6,000,000 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |